AAAAAA

   
Results: 1-9 |
Results: 9
EFFICACY, SAFETY, AND DOSE-RESPONSE OF 3 DOSES OF SERTINDOLE AND 3 DOSES OF HALDOL IN SCHIZOPHRENIC-PATIENTS
Authors: SCHULZ SC MACK R ZBOROWSKI J MORRIS D SEBREE T WALLIN B
Citation: Sc. Schulz et al., EFFICACY, SAFETY, AND DOSE-RESPONSE OF 3 DOSES OF SERTINDOLE AND 3 DOSES OF HALDOL IN SCHIZOPHRENIC-PATIENTS, Schizophrenia research, 18(2-3), 1996, pp. 6-6
BRAIN IMAGING TO DETERMINE THE EFFECTS OF SERTINDOLE IN A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL IN SCHIZOPHRENIC-PATIENTS
Authors: POTKIN S ZBOROWSKI J WU J GILES K BERA R HENRY M SEBREE T AURANG C WALLIN B BUNNEY W
Citation: S. Potkin et al., BRAIN IMAGING TO DETERMINE THE EFFECTS OF SERTINDOLE IN A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL IN SCHIZOPHRENIC-PATIENTS, Schizophrenia research, 18(2-3), 1996, p.
BRAIN IMAGING TO DETERMINE THE EFFECTS OF SERTINDOLE IN SCHIZOPHRENIC-PATIENTS
Authors: POTKIN SG ZBOROWSKI J WU J MACK R AURANG C SEBREE T CARREON D BERA R
Citation: Sg. Potkin et al., BRAIN IMAGING TO DETERMINE THE EFFECTS OF SERTINDOLE IN SCHIZOPHRENIC-PATIENTS, Psychopharmacology bulletin, 32(3), 1996, pp. 498-498
EFFECT OF RENAL IMPAIRMENT ON THE PHARMACOKINETICS OF A NEW DOPAMINERGIC SELECTIVE ANTIPSYCHOTIC COMPOUND
Authors: WONG SL SEBREE T MENACHERRY S MULFORD D LINNEN P GRANNEMAN GR
Citation: Sl. Wong et al., EFFECT OF RENAL IMPAIRMENT ON THE PHARMACOKINETICS OF A NEW DOPAMINERGIC SELECTIVE ANTIPSYCHOTIC COMPOUND, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 108-108
BRAIN IMAGING TO DETERMINE THE EFFECTS OF SERTINDOLE IN SCHIZOPHRENIC-PATIENTS
Authors: POTKIN S ZBOROWSKI J WU J MACK R BERA R SEBREE T AURANG C BUNNEY W
Citation: S. Potkin et al., BRAIN IMAGING TO DETERMINE THE EFFECTS OF SERTINDOLE IN SCHIZOPHRENIC-PATIENTS, Biological psychiatry, 39(7), 1996, pp. 52-52
EFFICACY AND SAFETY OF 3 DOSES OF SERTINDOLE AND HALOPERIDOL IN SCHIZOPHRENIC-PATIENTS
Authors: BARK N MACK R ZBOROWSKI J MORRIS D SEBREE T SHOOK S WALLIN B
Citation: N. Bark et al., EFFICACY AND SAFETY OF 3 DOSES OF SERTINDOLE AND HALOPERIDOL IN SCHIZOPHRENIC-PATIENTS, Biological psychiatry, 39(7), 1996, pp. 332-332
EFFICACY AND SAFETY OF SERTINDOLE IN A TRIAL OF SCHIZOPHRENIC-PATIENTS
Authors: ZBOROWSKI J SCHMITZ P STASER J ONEIL J GILES K WALLIN B SEBREE T TAMMINGA C
Citation: J. Zborowski et al., EFFICACY AND SAFETY OF SERTINDOLE IN A TRIAL OF SCHIZOPHRENIC-PATIENTS, Biological psychiatry, 37(9), 1995, pp. 661-662
A PILOT-STUDY OF THE EFFICACY AND SAFETY OF A-81418 IN REDUCING SYMPTOMS OF NICOTINE WITHDRAWAL
Authors: GREBB JA KITTLE C SEBREE T KASHKIN KB
Citation: Ja. Grebb et al., A PILOT-STUDY OF THE EFFICACY AND SAFETY OF A-81418 IN REDUCING SYMPTOMS OF NICOTINE WITHDRAWAL, Biological psychiatry, 35(9), 1994, pp. 691-691
A PLACEBO-CONTROLLED TRIAL OF SERTINDOLE IN SCHIZOPHRENIA
Authors: GREBB JA SEBREE T SCHMITZ P KASHKIN K
Citation: Ja. Grebb et al., A PLACEBO-CONTROLLED TRIAL OF SERTINDOLE IN SCHIZOPHRENIA, Neuropsychopharmacology, 9(2), 1993, pp. 190000119-190000120
Risultati: 1-9 |